SYK:NYSEStryker Corporation Analysis
Data as of 2026-02-21 - not real-time
$380.23
Latest Price
3/10Risk
Risk Level: Low
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Trading near short-term resistance levels.
- RSI is neutral at 57.0 with a recent Doji indecision pattern.
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong momentum from new trauma product launches.
- Consistent revenue growth and expanding operating margins.
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Aging demographic trends support long-term orthopedic demand.
- Stryker's market leadership and consistent dividend growth history.
Key Metrics & Analysis
Financial Health
Revenue Growth9.50%
Profit Margin16.50%
P/E Ratio44.4
ROE15.50%
ROA8.50%
Debt/Equity0.66
P/B Ratio6.5
Op. Cash Flow$3.9B
Free Cash Flow$3.1B
Industry P/E18.3
Technical Analysis
TrendBullish
RSI57.0
Support$360.05
Resistance$404.87
MA 20$374.50
MA 50$360.05
MA 200$368.95
MACDBullish
VolumeStable
Fear & Greed Index65
Valuation
Fair Value$340.50
Target Price$426.94
Upside/Downside12.28%
GradeOvervalued
TypeGrowth
Dividend Yield0.91%
Risk Assessment
Beta0.87
Volatility18.50%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.